| Arleta Foot Care, Inc. | |
|
9068 Woodman Ave, Arleta, CA 91331-6403 | |
| (818) 892-3196 | |
| (818) 830-6700 |
| Full Name | Arleta Foot Care, Inc. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist - Primary Podiatric Medicine |
| Location | 9068 Woodman Ave, Arleta, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891189551 | NPI | - | NPPES |
| 000E40890 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | E4089 (California) | Primary |
| Provider Name | Abid N Chaudhry |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1891875126 PECOS PAC ID: 1254488083 Enrollment ID: I20090414000622 |
News Archive
Personalized medicine or "precision medicine" is the most significant trend in 21st century medicine. "It's all about the right treatment for the right patient at the right time," says Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometry.
Non-Europeans have a higher frequency of the gene variants that increase the risk of lupus as compared to the European population, a new study from researchers at the National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' and King's College London, has confirmed.
The allure of high-intensity interval training is simple – go all-out for as little as one minute and reap the benefits of a 45 or 60-minute workout. With a promise like that, it is easy to understand why people are willing to try it.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arleta Foot Care, Inc. 9068 Woodman Ave., Arleta, CA 91331-6403 Ph: (818) 892-3196 | Arleta Foot Care, Inc. 9068 Woodman Ave, Arleta, CA 91331-6403 Ph: (818) 892-3196 |
News Archive
Personalized medicine or "precision medicine" is the most significant trend in 21st century medicine. "It's all about the right treatment for the right patient at the right time," says Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometry.
Non-Europeans have a higher frequency of the gene variants that increase the risk of lupus as compared to the European population, a new study from researchers at the National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' and King's College London, has confirmed.
The allure of high-intensity interval training is simple – go all-out for as little as one minute and reap the benefits of a 45 or 60-minute workout. With a promise like that, it is easy to understand why people are willing to try it.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of an intent to grant for the "Manoharan II" patent series (EP Application No 04 718 537), titled "Therapeutic Compositions." The new patent includes 16 claims covering compositions and methods, including pharmaceutical compositions, for chemically modified siRNAs containing phosphorothioate and 2′-O-alkyl modifications without any siRNA length restrictions.
› Verified 8 days ago
Abid Nazir Chaudhry, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9068 Woodman Ave, Arleta, CA 91331 Phone: 818-892-3196 Fax: 818-830-6700 |